• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.03% Nasdaq Up 0.33%

    AbbVie Inc. (ABBV)

    -NYSE
    70.16 Down 0.61(0.86%) Jul 30, 4:02PM EDT
    |After Hours : 69.80 Down 0.36 (0.51%) Jul 30, 6:15PM EDT
    Add to Portfolio
    Prev Close:70.77
    Open:70.86
    Bid:68.14 x 100
    Ask:70.33 x 100
    1y Target Est:75.80
    Beta:1.56
    Next Earnings Date:N/A
    Day's Range:69.27 - 70.88
    52wk Range:51.37 - 71.60
    Volume:6,820,441
    Avg Vol (3m):9,642,650
    Market Cap:111.77B
    P/E (ttm):54.56
    EPS (ttm):1.29
    Div & Yield:2.04 (3.00%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 0.86%111.77B
    MRKDown 0.03%165.33B
    NVSDown 0.49%249.20B
    PFEDown 0.08%220.01B

    Key Statistics

    Forward P/E (1 yr):13.95
    P/S (ttm):5.37
    Ex-Dividend Date:13-Jul-15

    Analysts

    Annual EPS Est (Dec-15) :4.25
    Quarterly EPS Est (Sep-15) :1.07
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):1.00

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback